Development, distribution and licensing agreement for Architect immunochemistry diagnostics platformDevelopment, Distribution and Licensing Agreement • April 15th, 2022 • Delaware
Contract Type FiledApril 15th, 2022 JurisdictionDevelopment and commercialization agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression of heart failure.